The stock of Bristol-Myers Squibb Co (BMY) is currently priced at $47.34. In the last session, the stock climbed significantly, topping out at $68.0 after opening at $47.34. The day’s lowest price was $36.0 before the stock closed at $46.86.
Bristol-Myers Squibb Co’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $63.33 on 03/11/25 and a low of $39.92 for the same time frame on 07/15/24.
52-week price history of BMY Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Bristol-Myers Squibb Co’s current trading price is -25.25% away from its 52-week high, while its distance from the 52-week low is 18.57%. The stock’s price range during the 52-week period has remained between $39.92 and $63.33. In the Healthcare sector, the company’s shares saw a trading volume of around 10.87 million for the day, which was evidently lower than the average daily volume of 14.96 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Bristol-Myers Squibb Co (BMY) has experienced a quarterly decline of -6.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 96.34B and boasts a workforce of 34100 employees.
A Closer Look at Analysts’ Ratings for Bristol-Myers Squibb Co
As of right now, 3 analysts are rating Bristol-Myers Squibb Co as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 18 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 51.93, with a change in price of -7.09. Similarly, Bristol-Myers Squibb Co recorded 14,255,475 in trading volume during the last 100 days, posting a change of -13.03%.
Examining BMY’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 2.95. Similarly, the long-term debt-to-equity ratio is also 2.73.
BMY Stock Stochastic Average
As of today, Bristol-Myers Squibb Co’s raw stochastic average for the last 50 days stands at 49.41%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 27.36%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 31.27% and 32.85%, respectively.
BMY Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 15.13% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -16.67%. Over the past 30 days, the price of BMY has leaped by -5.62%. And in the last five days, it has surged by 1.83%.
